HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kemal Haque Selected Research

Phosphatidylinositol 3-Kinases (PI 3 Kinase)

12/2021Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kemal Haque Research Topics

Disease

1B-Cell Lymphoma (Lymphoma, B Cell)
12/2021
1Neoplasms (Cancer)
01/2021
1Fibrosis (Cirrhosis)
05/2012

Drug/Important Bio-Agent (IBA)

1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
12/2021
1Histone Deacetylase 6IBA
01/2021
1Matrix Metalloproteinases (MMPs)IBA
05/2012
1Matrix Metalloproteinase InhibitorsIBA
05/2012
1CollagenIBA
05/2012
1ProcollagenIBA
05/2012